Recently, the roles of CDK4 have been reported as follows: i) high CDK4 alterations occur in DDLPS among soft tissue sarcomas, ii) CDK4 alteration correlates with worse overall survival, and iii) the levels of CDK4 and MDM2 are not always consistent (11). This evidence concerns the gene CDK4 and soft tissue sarcoma.